NeueHealth, Inc. (NYSE:NEUE – Get Free Report) CFO Jay Matushak sold 4,448 shares of the company’s stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $6.74, for a total value of $29,979.52. Following the sale, the chief financial officer now owns 41,592 shares in the company, valued at approximately $280,330.08. This trade represents a 9.66 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
Jay Matushak also recently made the following trade(s):
- On Tuesday, March 11th, Jay Matushak sold 814 shares of NeueHealth stock. The shares were sold at an average price of $6.85, for a total value of $5,575.90.
- On Friday, March 7th, Jay Matushak sold 1,860 shares of NeueHealth stock. The shares were sold at an average price of $7.19, for a total value of $13,373.40.
- On Monday, January 6th, Jay Matushak sold 4,970 shares of NeueHealth stock. The shares were sold at an average price of $7.33, for a total value of $36,430.10.
NeueHealth Stock Performance
NEUE opened at $4.85 on Thursday. The business’s 50-day simple moving average is $7.11 and its 200-day simple moving average is $6.00. The company has a market cap of $40.18 million, a P/E ratio of -0.09 and a beta of 0.56. NeueHealth, Inc. has a one year low of $3.79 and a one year high of $7.66.
Analysts Set New Price Targets
Get Our Latest Stock Analysis on NEUE
Institutional Inflows and Outflows
Hedge funds have recently added to or reduced their stakes in the company. Partners Group Holding AG purchased a new position in NeueHealth during the 3rd quarter worth approximately $463,000. Northern Trust Corp grew its stake in NeueHealth by 66.8% during the 4th quarter. Northern Trust Corp now owns 32,644 shares of the company’s stock worth $242,000 after buying an additional 13,074 shares during the last quarter. Finally, Virtu Financial LLC purchased a new position in NeueHealth during the 4th quarter worth approximately $76,000. Hedge funds and other institutional investors own 63.88% of the company’s stock.
NeueHealth Company Profile
NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.
Featured Stories
- Five stocks we like better than NeueHealth
- Growth Stocks: What They Are, Examples and How to Invest
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- What is an Earnings Surprise?
- Alphabet’s Officially In A Bear Market—Time To Buy?
- What Are Dividend Champions? How to Invest in the Champions
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.